Search
for

    Glossary Clobetasol

    potent topical corticosteroid for treating inflammatory skin conditions

    Clobetasol, often referred to as Clobetasol Propionate, is a potent topical corticosteroid used to treat various skin conditions, including eczema, psoriasis, and alopecia areata. It works by reducing inflammation, itching, and redness, providing relief from symptoms.

    Related Terms

    Sort by

    Research 30 of 967

    1. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis Journal of the American Academy of Dermatology · 2003 · 146 citations
    2. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial Journal of the European Academy of Dermatology and Venereology · 2006 · 114 citations
    3. Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects Journal of Controlled Release · 2015 · 69 citations
    4. Effect of physical stimuli on hair follicle deposition of clobetasol-loaded Lipid Nanocarriers Scientific Reports · 2020 · 52 citations
    5. Clobetasol Propionate, 0.05%, vs Hydrocortisone, 1%, for Alopecia Areata in Children JAMA dermatology · 2013 · 49 citations
    6. Comparison of Systemic Mycophenolate Mofetil with Topical Clobetasol in Lichen Planopilaris: A Parallel-Group, Assessor- and Analyst-Blinded, Randomized Controlled Trial American journal of clinical dermatology · 2015 · 26 citations
    7. The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata Journal of Dermatological Treatment · 2011 · 13 citations
    8. Chromatographic method for clobetasol propionate determination in hair follicles and in different skin layers Biomedical Chromatography · 2016 · 12 citations
    9. Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial Journal of Dermatological Treatment · 2020 · 11 citations
    10. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study Dermatology and therapy · 2020 · 10 citations
    11. Efficacy of topical tacrolimus 0.1% and clobetasol propionate 0.05% in the treatment of alopecia areata Journal of Pakistan Association of Dermatologists · 2016 · 2 citations
    12. Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study Journal of cosmetic dermatology · 2022 · 1 citations
    13. Comparative Evaluation of Efficacy Between Topical Calcipotriol Used Along With Topical Clobetasol And Topical Clobetasol Monotherapy In Treatment Of Alopecia Areata: A Randomised Clinical Trial Journal of clinical and diagnostic research · 2021 · 1 citations
    14. Topical Metformin Compared with Clobetasol Propionate for Alopecia Areata: Clinical Outcomes from a Comparative Study PubMed Central · 2026
    15. Topical Tacrolimus, Clobetasol, and Minoxidil (TCM) for Primary Cicatricial Alopecias: A Retrospective Analysis of Clinical Outcomes and Safety Skin Appendage Disorders · 2025
    16. Evaluation of The Effects and Side Effects of Topical Clobetasol 0.05% and Topical Anthralin Treatment in Alopecia Areata with Phototricogram Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi · 2024
    17. Un caso de alopecia areata con repoblación paradójica espontánea con buena respuesta a propionato de clobetasol Medicina cutánea ibero-latino-americana · 2017
    18. Drug delivery to the hair follicle : role of follicular tight junctions as a biological barrier and the potential for targeting clobetasol nanocarriers SciDok (Saarland University and State Library) · 2015
    19. COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA Pakistan Journal of Intensive Care Medicine · 2025
    20. Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions. PubMed · 2025
    21. Compatibility of Caffeine Clobetasol Propionate Dutasteride Nicotinamide and Progesterone in TrichoFoam™, a Natural Vehicle for Hair Foams. PubMed · 2024
    22. Comparative Efficacy of Topical Tacrolimus 0.1% and Clobetasol Propionate 0.05% in the Treatment of Alopecia Areata (AA) Pakistan Journal of Health Sciences · 2023
    23. Efficacy of Low Level Laser Therapy Combined with Scalp Microneedling using Clobetasol Propionate 0,05% Solution for the Management of Androgenetic Alopecia Journal of medical and health studies · 2023
    24. Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata Iraqi postgraduate medical journal · 2023
    25. Bimatoprost versus clobetasol propionate in scalp alopecia areata: A prospective non-randomized open-label clinical trial Indian Dermatology Online Journal · 2023
    26. Efficacy of Topical Clobetasol Propionate 0.05% Ointment and Topical Tacrolimus 0.1% Ointment in Treatment of Alopecia Areata.: RCT Pakistan Journal of Medical and Health Sciences · 2022
    27. Alopesi areata hastalarında topikal kortikosteroid (%0.05 Klobetasol Propionat) tedavisi ile % 1 topikal pimekrolimus tedavisinin karşılaştırılması / Comparison of topical corticosteroid (%0.05 Clobetasol propionate) treatment and %1 pimecrolimus treatment in alopesia areata patients 2009
    28. Clobetasol/minoxidil Reactions Weekly · 2023
    29. Telogen effluvium: a comprehensive review Clinical, Cosmetic and Investigational Dermatology · 2019 · 56 citations
    30. Erosive pustular dermatosis of the scalp: Clinical, trichoscopic, and histopathologic features of 20 cases Journal of The American Academy of Dermatology · 2017 · 53 citations